Covaxin trials for kids from June 1: Crucial to prevent third wave?
There is growing concern among people ahead of the third wave threat of coronavirus. As speculations are rife that the third wave of covid-19 is likely to affect a larger population of children, the central government got alerted. According to the reports, before the onset of the third wave of COVID-19, the government aims to vaccinate as many children as possible, as there is growing consensus that the younger population is at greater risk in the next wave.
Reports suggest that the phase-3 clinical trials for Bharat Biotech's COVID-19 vaccine, Covaxin, will begin from June 1 in the age group of 2-18 years.